Catalyst Names Niklas Morton as First Chief Operating Officer
Veteran Biotech Executive Will Direct Operations, Help Shape Growth Strategy Wilmington, NC, 5 April 2022 – Niklas Morton, a seasoned industry executive with extensive experience at PPD and SmithKline Beecham (now GSK), has joined Catalyst Clinical Research as chief...
Development of Novel Wearables and AI Capabilities to Support the Monitoring of COVID-19 Patients
As the COVID-19 pandemic developed, it soon emerged that hospital staff faced significant challenges in identifying/predicting which patients would need critical care. This became increasingly important as COVID-19 increased, stretching the capacity of ward staff to...
Catalyst Clinical Research, Ledger Run Expand Strategic Partnership To Accelerate Research, Streamline Clinical Operations
Catalyst Streamlines Business Processes with New Technologies Wilmington, NC and Tiburon, CA – 8 February 2022 – Catalyst Clinical Research, a leading provider of clinical research services, and Ledger Run, a leading innovator in clinical operations technology, will...
Catalyst CEO Nick Dyer Named to 2021 ‘Wilmington Biz 100,’ Described as Community ‘Innovator’
Wilmington Business Publication Highlights Accomplishments of Regional Leaders Wilmington, NC, 8 December 2021 – Catalyst CEO Nick Dyer was recognized as one of Wilmington’s top business leaders in 2021 by the WilmingtonBiz publication. Catalyst is headquartered...
